Author

Carine Beysen

Observed names: Beysen C., Beysen, Carine, C BEYSEN, C. Beysen, CARINE BEYSEN

Observed institutions: Otsuka (Japan), Tufts University, United States Department of Agriculture, University of California, San Francisco, Touro University California, Maastricht University, University of Oxford, Western Human Nutrition Research Center, Jean Mayer Human Nutrition Research Center on Aging, Oxford Centre for Diabetes, Endocrinology and Metabolism, KineMed (United States), University of California, Davis

ORCID: 0000-0002-2259-0932

Observed ORCID: 0000-0002-2259-0932

OpenAlex ID: A5035102402

Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans

2009 · Kimber L. Stanhope, Jean Marc Schwarz, et al. · Journal of Clinical Investigation · 1,800

PDF

Substituting dietary saturated fat with polyunsaturated fat changes abdominal fat distribution and improves insulin sensitivity

2002 · L. K. M. Summers, B. A. Fielding, et al. · Diabetologia · 418

PDF

Acetyl‐CoA Carboxylase Inhibition Reverses NAFLD and Hepatic Insulin Resistance but Promotes Hypertriglyceridemia in Rodents

2018 · Leigh Goedeke, Jamie Bates, et al. · Hepatology · 261

Measurement of protein turnover rates by heavy water labeling of nonessential amino acids

2006 · R BUSCH, Y KIM, et al. · Biochimica et Biophysica Acta (BBA) - General Subjects · 255

Potential Mechanisms Leading to the Abnormal Lipid Profile in Patients With Rheumatoid Arthritis Versus Healthy Volunteers and Reversal by Tofacitinib

2014 · Christina Charles‐Schoeman, Roy Fleischmann, et al. · Arthritis & Rheumatology · 193

PDF

Effect of bile acid sequestrants on glucose metabolism, hepatic de novo lipogenesis, and cholesterol and bile acid kinetics in type 2 diabetes: a randomised controlled study

2011 · C. Beysen, E. J. Murphy, et al. · Diabetologia · 164

PDF

MicroRNA-29 Fine-tunes the Expression of Key FOXA2-Activated Lipid Metabolism Genes and Is Dysregulated in Animal Models of Insulin Resistance and Diabetes

2014 · C. Lisa Kurtz, Bailey C.E. Peck, et al. · Diabetes · 119

Acetyl‐coenzyme A carboxylase inhibition reduces de novo lipogenesis in overweight male subjects: A randomized, double‐blind, crossover study

2017 · Kathryn Stiede, Wenyan Miao, et al. · Hepatology · 115

PDF

Interaction between specific fatty acids, GLP-1 and insulin secretion in humans

2002 · Beysen C., Karpe F., et al. · Diabetologia · 105

PDF

Identifying nonalcoholic fatty liver disease patients with active fibrosis by measuring extracellular matrix remodeling rates in tissue and blood

2016 · Martin L. Decaris, Kelvin W. Li, et al. · Hepatology · 100

PDF

Decreasing the Rate of Metabolic Ketone Reduction in the Discovery of a Clinical Acetyl-CoA Carboxylase Inhibitor for the Treatment of Diabetes

2014 · David A. Griffith, Daniel W. Kung, et al. · Journal of Medicinal Chemistry · 93

PDF

Uptake of individual fatty acids into adipose tissue in relation to their presence in the diet

2000 · Lucinda KM Summers, Sophie C Barnes, et al. · American Journal of Clinical Nutrition · 90

Dietary sucrose is essential to the development of liver injury in the methionine-choline-deficient model of steatohepatitis

2009 · Michael K. Pickens, Jim S. Yan, et al. · Journal of Lipid Research · 89

Dietary sugar restriction reduces hepatic de novo lipogenesis in adolescent boys with fatty liver disease

2021 · Catherine C. Cohen, Kelvin W. Li, et al. · Journal of Clinical Investigation · 86

PDF

Metabolic responses to prolonged consumption of glucose- and fructose-sweetened beverages are not associated with postprandial or 24-h glucose and insulin excursions

2011 · Kimber L Stanhope, Steven C Griffen, et al. · American Journal of Clinical Nutrition · 84

PDF

Human sebum requires de novo lipogenesis, which is increased in acne vulgaris and suppressed by acetyl-CoA carboxylase inhibition

2019 · William P. Esler, Gregory J. Tesz, et al. · Science Translational Medicine · 68

Sotagliflozin Decreases Postprandial Glucose and Insulin Concentrations by Delaying Intestinal Glucose Absorption

2019 · David R Powell, Brian Zambrowicz, et al. · The Journal of Clinical Endocrinology & Metabolism · 60

Beta cell secretion of miR-375 to HDL is inversely associated with insulin secretion

2019 · Leslie R. Sedgeman, Carine Beysen, et al. · Scientific Reports · 55

PDF

Uncovering a Predictive Molecular Signature for the Onset of NASH-Related Fibrosis in a Translational NASH Mouse Model

2017 · Arianne van Koppen, Lars Verschuren, et al. · Cellular and Molecular Gastroenterology and Hepatology · 55

PDF

Inhibition of fatty acid synthase with FT‐4101 safely reduces hepatic de novo lipogenesis and steatosis in obese subjects with non‐alcoholic fatty liver disease: Results from two early‐phase randomized trials

2020 · Carine Beysen, Patricia Schroeder, et al. · Diabetes Obesity and Metabolism · 54

PDF

Dose-dependent quantitative effects of acute fructose administration on hepatic de novo lipogenesis in healthy humans

2018 · Carine Beysen, Marcella Ruddy, et al. · American Journal of Physiology-Endocrinology and Metabolism · 41

PDF

A pilot study of the effects of pioglitazone and rosiglitazone on de novo lipogenesis in type 2 diabetes

2008 · Carine Beysen, Elizabeth J. Murphy, et al. · Journal of Lipid Research · 39

Whole-Body Glycolysis Measured by the Deuterated-Glucose Disposal Test Correlates Highly With Insulin Resistance In Vivo

2007 · Carine Beysen, Elizabeth J. Murphy, et al. · Diabetes Care · 33

140-LB: NGM313, a Novel Activator of b-Klotho/FGFR1c, Improves Insulin Resistance and Reduces Hepatic Fat in Obese, Nondiabetic Subjects

2019 · ALEX DEPAOLI, VAN PHUNG, et al. · Diabetes · 28

Altered subcutaneous abdominal adipose tissue lipid synthesis in obese, insulin-resistant humans

2013 · Demidmaa Tuvdendorj, Manisha Chandalia, et al. · American Journal of Physiology-Endocrinology and Metabolism · 28

Works count: 50

Citation count: 4,592

H-index: 25

I10-index: 33